Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Acute interstitial nephritis with Prothionamide

View through CrossRef
Among drug-related complications, drug-related nephrotoxicity is the commonest. It is the cause for 7% of all drug-related toxicities among inpatients and accounts for 20% to 30% of acute renal failure. Acute interstitial nephritis is one of the drug-related adverse reactions and occurs due to a drug-related type 4 hypersensitivity reaction. In this case report, we reported acute interstitial nephritis that causes acute renal failure (acute kidney injury) in a patient taking Prothionamide therapy. This drug-related side effect had not been reported. In this case report, we report a patient who develops fatigability, rash, and intermittent fever after 14 days of taking the drug Prothionamide. The main aims of this case report are to use it as a pharmacovigilance report for drug-producing companies and to consider a further study on this side effect. It is also an alert for clinicians to consider this side effect when patients develop acute interstitial nephritis while taking Prothionamide.
Title: Acute interstitial nephritis with Prothionamide
Description:
Among drug-related complications, drug-related nephrotoxicity is the commonest.
It is the cause for 7% of all drug-related toxicities among inpatients and accounts for 20% to 30% of acute renal failure.
Acute interstitial nephritis is one of the drug-related adverse reactions and occurs due to a drug-related type 4 hypersensitivity reaction.
In this case report, we reported acute interstitial nephritis that causes acute renal failure (acute kidney injury) in a patient taking Prothionamide therapy.
This drug-related side effect had not been reported.
In this case report, we report a patient who develops fatigability, rash, and intermittent fever after 14 days of taking the drug Prothionamide.
The main aims of this case report are to use it as a pharmacovigilance report for drug-producing companies and to consider a further study on this side effect.
It is also an alert for clinicians to consider this side effect when patients develop acute interstitial nephritis while taking Prothionamide.

Related Results

ASSOCIATION BETWEEN THE PROTON PUMP INHIBITOR USE AND INCREASED HAZARD OF INTERSTITIAL NEPHRITIS
ASSOCIATION BETWEEN THE PROTON PUMP INHIBITOR USE AND INCREASED HAZARD OF INTERSTITIAL NEPHRITIS
Background: Proton pump inhibitors (PPIs), widely used to manage gastric acid-related disorders, have been increasingly linked to renal complications, particularly interstitial nep...
Frequency of Interstitial Nephritis in Patients Taking Proton Pump Inhibitor
Frequency of Interstitial Nephritis in Patients Taking Proton Pump Inhibitor
Background: Acute interstitial nephritis (AIN), a major cause of drug-induced acute kidney injury (AKI) and possible chronic kidney disease (CKD) is linked to extended PPI use. Pro...
Tough Decision Making in Pembrolizumab-Associated Acute Interstitial Nephritis: A Case Report
Tough Decision Making in Pembrolizumab-Associated Acute Interstitial Nephritis: A Case Report
Pembrolizumab is an immune checkpoint inhibitor used as a cancer therapy. The incidence of immune related adverse events in patients receiving immune checkpoint inhibitors can be a...
Dissecting signalling pathways associated with intrarenal synthesis of complement components in lupus nephritis
Dissecting signalling pathways associated with intrarenal synthesis of complement components in lupus nephritis
Lupus nephritis is one of the most common and serious complications of systemic lupus erythematosus, attributed to increased morbidity and mortality. The in situ deposition of intr...
Highly cationic anti‐DNA antibodies in patients with lupus nephritis analyzed by two‐dimensional electrophoresis and immunoblotting
Highly cationic anti‐DNA antibodies in patients with lupus nephritis analyzed by two‐dimensional electrophoresis and immunoblotting
AbstractThe relationship between chemical properties of anti‐DNA antibodies (Abs) and lupus nephritis was investigated. The anti‐DNA Abs in sera from systemic lupus erythematosus (...
Biomarker discovery in systemic lupus erythematosus: genome-methylation approaches : Research report
Biomarker discovery in systemic lupus erythematosus: genome-methylation approaches : Research report
Discovery of novel biomarkers in lupus nephritis Biomarkers are needed for making diagnosis and prognosis. In lupus nephritis, conventional tests like urinalysis or serum creatinin...

Back to Top